REAN Foundation

    • Register
    • Login
    • Search
    • Categories
    • Unread
    • Recent
    • Tags
    • Popular
    • Admin

    Simple Screening Tool Assesses Cognitive Impairment Post-COVID

    Healthcare Technologies
    2
    2
    36
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • S
      Shreemoyee last edited by

      Patients with post-COVID syndrome have long-term cognitive impairment that can last for more than 3 months and can be identified with the Oxford Cognitive Screen-Plus assessment, which is cost-effective, mobile, and easily used. Having a cost-effective, mobile way of assessing cognitive impairment in patients with post-COVID syndrome can provide important information that can help with predicting outcomes and making decisions regarding treatment. This can be especially helpful for patients living in rural, medically underserved areas and for other patients without needing a referral to a specialized medical facility.

      S 1 Reply Last reply Reply Quote 0
      • S
        Sandipan @Shreemoyee last edited by

        @shreemoyee During the initial interviews, 69.9% of patients complained of having attentional issues, 58.9% complained of having memory problems, and 55.7% of patients complained of both. In assessing fatigue and depression, with the Brief Fatigue Inventory and the Patient Health Questionnaire-9, respectively, the patients had significantly worse scores for both than the controls (P < .0001 for both).

        1 Reply Last reply Reply Quote 0
        • First post
          Last post